BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
14 results:

  • 1. Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
    Poon C; Hyde S; Grant P; Newman M; Ireland Jenkin K
    Int J Gynecol Cancer; 2016 Oct; 26(8):1415-20. PubMed ID: 27488216
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].
    Sedláková I; Laco J; Tošner J; Špaček J
    Ceska Gynekol; 2015 Dec; 80(6):405-13. PubMed ID: 26741154
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
    Patrono MG; Iniesta MD; Malpica A; Lu KH; Fernandez RO; Salvo G; Ramirez PT
    Gynecol Oncol; 2015 Dec; 139(3):568-72. PubMed ID: 26407480
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
    Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
    Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients].
    Sedláková I; Laco J; Tošner J; Spaček J; Cermáková E
    Ceska Gynekol; 2013 Dec; 78(6):545-53. PubMed ID: 24372433
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
    Wethington SL; Park KJ; Soslow RA; Kauff ND; Brown CL; Dao F; Otegbeye E; Sonoda Y; Abu-Rustum NR; Barakat RR; Levine DA; Gardner GJ
    Int J Gynecol Cancer; 2013 Nov; 23(9):1603-11. PubMed ID: 24172097
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Proteins of resistance and drug resistance in ovarian carcinoma patients].
    Sedláková I; Laco J; Tošner J; Caltová K; Cervinka M; Rezáč A; Spaček J; Skapinec P
    Klin Onkol; 2012; 25(6):457-63. PubMed ID: 23301649
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.
    Diaz-Padilla I; Amir E; Marsh S; Liu G; Mackay H
    Gynecol Oncol; 2012 Feb; 124(2):354-65. PubMed ID: 22063461
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
    Chu SM; Ming YC; Chao HC; Lai JY; Chen JC; Yung CP; Luo CC
    Chang Gung Med J; 2010; 33(2):152-6. PubMed ID: 20438667
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.
    Tiersten AD; Moon J; Smith HO; Wilczynski SP; Robinson WR; Markman M; Alberts DS
    Oncology; 2009; 77(6):395-9. PubMed ID: 20130422
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years' experience in the Kinki District of Japan (1990-2006).
    Kokawa K; Mikami Y; Sakata H; Oki N; Tanakas T; Yamazaki M; Nakata Y; Umesaki N
    Eur J Gynaecol Oncol; 2009; 30(2):155-61. PubMed ID: 19480244
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.
    Legge F; Petrillo M; Adamo V; Pisconti S; Scambia G; Ferrandina G
    BMC Cancer; 2008 Dec; 8():367. PubMed ID: 19077269
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Assesment of selected parameters depending on the size of abdominal wall incision in patients subjected to minilaparotomy due to benign gynaecological diseases].
    Malinowski A; Matyszewski A; Bartosiak-Majcher I; Wojciechowski M
    Ginekol Pol; 2008 Mar; 79(3):192-7. PubMed ID: 18592854
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.